Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Clinically+amyopathic+dermatomyositis%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Clinically+amyopathic+dermatomyositis%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Clinically+amyopathic+dermatomyositis%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (10)
1
Comparison of efficacy between tacrolimus and cyclosporine for the treatment of polymyositis/dermatomyositis-associated interstitial lung disease : Comparison of efficacy between tacrolimus and cyclosporine for the treatment of polymyositis/dermatomyositis-associated interstitial lung disease - Comparison between tacrolimus and cyclosporine for the treatment of PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trial : Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trial - Combination therapy of corticosteroid and tacrolimus for anti-MDA5 antibody-positive DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Significance of myositis-specific autoantibodies (MSA) for clinical features in polymyositis/dermatomyositis-associated interstitial lung disease : Significance of myositis-specific autoantibodies (MSA) for clinical features in polymyositis/dermatomyositis-associated interstitial lung disease - MSA in PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trial : Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trial - Corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for anti-ARS antibody-positive PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Comparison of efficacy between tacrolimus and cyclosporine for the treatment of polymyositis/dermatomyositis-associated interstitial lung disease : Comparison of efficacy between tacrolimus and cyclosporine for the treatment of polymyositis/dermatomyositis-associated interstitial lung disease - Comparison between tacrolimus and cyclosporine for the treatment of PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trial : Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trial - Combination therapy of corticosteroid and tacrolimus for anti-MDA5 antibody-positive DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Significance of myositis-specific autoantibodies (MSA) for clinical features in polymyositis/dermatomyositis-associated interstitial lung disease : Significance of myositis-specific autoantibodies (MSA) for clinical features in polymyositis/dermatomyositis-associated interstitial lung disease - MSA in PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trial : Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trial - Corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for anti-ARS antibody-positive PM/DM-ILD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis : An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2017
Wird geladen...
10
An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis : An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2017
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
10
WHO International Clinical Trials Registry Plat...
Thema
10
610
8
Study Type: Interventional
6
Recruitment Status: Recruiting
2
Medical Condition: Polymyositis/dermatomyositis...
2
Medical Condition: anti-aminoacyl-tRNA syntheta...
2
Medical Condition: anti-melanoma differentiatio...
2
Medical Condition: clinically amyopathic dermat...
2
Medical Condition: polymyositis/dermatomyositis...
2
Phase: Post-market
2
Recruitment Status: Complete: follow-up complete
2
Recruitment Status: Completed
2
Study Type: Observational
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...